Patents Assigned to Novozymes, Inc.
  • Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
    Publication number: 20190169588
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: February 12, 2019
    Publication date: June 6, 2019
    Applicant: Novozymes, Inc.
    Inventors: Suchindra Maiyuran, Randall Kramer, Paul Harris
  • Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
    Patent number: 10308921
    Abstract: The present invention provides isolated polypeptides having cellulolytic enhancing activity and polynucleotides encoding the polypeptides, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also provides nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: June 4, 2019
    Assignee: Novozymes, Inc.
    Inventors: Lan Tang, Ye Liu, Yu Zhang, Junxin Duan, Tarana Shaghasi
  • Filamentous fungal host cell for producing multiple recombinant polypeptides
    Patent number: 10301610
    Abstract: The present invention relates to methods for constructing a filamentous fungal strain for production of multiple recombinant polypeptides having biological activity. The present invention also relates to methods for producing multiple recombinant polypeptides having biological activity in a filamentous fungal strain. The present invention also relates to filamentous fungal strains expressing multiple recombinant polypeptides having biological activity.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: May 28, 2019
    Assignee: Novozymes, Inc.
    Inventors: Debbie Yaver, Qiming Jin
  • GH61 Polypeptide Variants and Polynucleotides Encoding Same
    Publication number: 20190153414
    Abstract: The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: February 6, 2019
    Publication date: May 23, 2019
    Applicants: Novozymes, Inc.
    Inventors: Janine Lin, Doreen Bohan, Michelle Maranta, Leslie Beresford, Michael Lamsa, Matt Sweeney, Mark Wogulis, Elizabeth Znameroski, Frank Winther Rasmussen
  • Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
    Patent number: 10280201
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: May 7, 2019
    Assignee: Novozymes, Inc.
    Inventors: Kimberly Brown, Paul Harris, Elizabeth Zaretsky, Edward Re, Elena Vlasenko, Keith McFarland, Alfredo Lopez de Leon
  • Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
    Patent number: 10280413
    Abstract: The present invention relates to isolated polypeptides having cellobiohydrolase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: May 7, 2019
    Assignee: Novozymes, Inc.
    Inventor: Nikolaj Spodsberg
  • Methods of degrading or hydrolyzing a polysaccharide
    Patent number: 10273512
    Abstract: The invention provides a method of degrading or hydrolyzing a polysaccharide, preferably cellulose or chitin, comprising contacting said polysaccharide with one or more oxidohydrolytic enzymes, preferably a CBM33 family protein (preferably CBP21) or a GH61 family protein, wherein said degradation or hydrolysis is carried out in the presence of at least one reducing agent and at least one divalent metal ion. A method of producing an organic substance comprising said method is also provided.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: April 30, 2019
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Gustav Vaaje-Kostad, Bjorge Westereng, Vincent G. H. Eijsink, Svein J. Horn, Morten Sorliie, Zarah Forsberg
  • Beta-glucosidase variants polynucleotides encoding same
    Patent number: 10260058
    Abstract: The present invention relates to beta-glucosidase variants, e.g., beta-glucosidase variants of a parent Family GH3A beta-glucosidase from Aspergillus fumigatus. The present invention also relates to polynucleotides encoding the beta-glucosidase variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the beta-glucosidase variants.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: April 16, 2019
    Assignee: Novozymes, Inc.
    Inventors: Mark Wogulis, Paul Harris, David Osborn
  • Polypeptides having catalase activity and polynucleotides encoding same
    Patent number: 10253342
    Abstract: The present invention relates to isolated polypeptides having catalase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: April 9, 2019
    Assignee: Novozymes Inc.
    Inventors: Ye Liu, Junxin Duan, Yu Zhang, Lan Tang
  • Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
    Patent number: 10246693
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: April 2, 2019
    Assignee: Novozymes, Inc.
    Inventors: Suchindra Maiyuran, Randall Kramer, Paul Harris
  • Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
    Patent number: 10246691
    Abstract: The present invention relates to variants of GH61 polypeptides having cellulolytic enhancing activity, wherein the variants comprise a substitution at one or more positions corresponding to positions 90, 131, 134, and 141 of the full-length polypeptide of SEQ ID NO: 2, and have cellulolytic enhancing activity. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: April 2, 2019
    Assignee: Novozymes, Inc.
    Inventors: Matthew Sweeney, Mark Wogulis
  • Methods for obtaining positive transformants of a filamentous fungal host cell
    Publication number: 20190093094
    Abstract: The present invention relates to methods for obtaining positive transformants of a filamentous fungal host cell, comprising: transforming a tandem construct into a population of cells of the filamentous fungal host a tandem construct and isolating a transformant of the filamentous fungal host cell comprising the tandem construct. The present invention also relates to such tandem constructs, filamentous fungal host cells comprising such tandem constructs, and methods of producing multiple recombinant proteins.
    Type: Application
    Filed: December 6, 2018
    Publication date: March 28, 2019
    Applicant: Novozymes, Inc.
    Inventor: Donna Moyer
  • Methods for Producing Polypeptides in Protease-Deficient Mutants of Trichoderma
    Publication number: 20190093143
    Abstract: The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.
    Type: Application
    Filed: December 6, 2018
    Publication date: March 28, 2019
    Applicant: Novozymes, Inc.
    Inventors: Suchindra Maiyuran, Abigail Jang, Kimberly Brown, Sandra Merino, Jeffrey Shasky, Eric Abbate
  • Cellulolytic enzyme compositions and uses thereof
    Patent number: 10233473
    Abstract: The present invention relates to recombinant filamentous fungal host cells producing cellulolytic enzyme compositions and methods of producing and using the compositions.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: March 19, 2019
    Assignee: Novozymes, Inc.
    Inventors: Jeffrey Shasky, Suchindra Maiyuran, Amanda Fischer
  • Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same
    Publication number: 20190078068
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: November 20, 2018
    Publication date: March 14, 2019
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Kirk Schnorr, Randall Kramer
  • GH61 polypeptide variants and polynucleotides encoding same
    Patent number: 10227579
    Abstract: The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 26, 2013
    Date of Patent: March 12, 2019
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Janine Lin, Doreen Bohan, Michelle Maranta, Leslie Beresford, Michael Lamsa, Matt Sweeney, Mark Wogulis, Elizabeth Znameroski, Frank Winther Rasmussen
  • Polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and polynucleotides encoding same
    Patent number: 10227614
    Abstract: The present invention relates to isolated polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: March 12, 2019
    Assignees: NOVOZYMES A/S, NOVOZYMES, INC.
    Inventor: Marc Morant
  • Cellobiohydrolase variants and polynucleotides encoding same
    Patent number: 10221406
    Abstract: The present invention relates to cellobiohydrolase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: March 5, 2019
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Kim Borch, Kenneth Jensen, Kristian Krogh, Brett McBrayer, Peter Westh, Jeppe Kari, Johan Olsen, Trine Sorensen, Michael Windahl, Hui Xu
  • Polypeptides having amylolytic enhancing activity and polynucleotides encoding same
    Patent number: 10221405
    Abstract: The present invention relates to isolated polypeptides having amylolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: March 5, 2019
    Assignee: NOVOZYMES, INC.
    Inventors: Paul Harris, Mark Wogulis
  • Cellobiohydrolase variants and polynucleotides encoding same
    Publication number: 20190055532
    Abstract: The present invention relates to variants of a parent cellobiohydrolase II. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: November 1, 2018
    Publication date: February 21, 2019
    Applicant: Novozymes, Inc.
    Inventor: Mark Wogulis